AFFiRiS, advised by E+H, announces license agreement with Frontier Biotechnologies for AFFITOPE® AT04 for the treatment of hypercholesterolemia
E+H advised AFFiRiS AG on the negotiation of an exclusive license agreement with Frontiers Biotechnologies Inc. AFFiRiS is an Austrian clinical stage biotechnology company. Frontier Biotechnologies Inc. is a publicly traded Chinese commercial-stage biopharmaceutical company. The agreement is to develop and commercialize AFFITOPE® AT04 to treat patients with hypercholesterolemia in Greater China, which consists of …
Antitrust law at E+H bolstered by new lawyer
The E+H antitrust team welcomes Felix Frommelt as an attorney who will fortify the practice!
KBC Group, advised by E+H, acquires Raiffeisenbank Bulgaria
E+H advised KBC Bank NV on an agreement to acquire 100% of the shares of Raiffeisenbank (Bulgaria) EAD, comprising the Bulgarian banking operations of Raiffeisen Bank International, for EUR 1,015 million. The transaction also includes Raiffeisen Leasing Bulgaria, Raiffeisen Asset Management, Raiffeisen Insurance Broker and Raiffeisen Service. Completion of the transaction is subject to regulatory …
Continue reading “KBC Group, advised by E+H, acquires Raiffeisenbank Bulgaria”
E+H goes Brussels – E+H welcomes Jochen Anweiler as partner in antitrust law and opens office in Brussels
As of 01 October 2021, Jochen Anweiler (54) has joined E+H as a partner in the antitrust practice group. Jochen Anweiler is an internationally recognized antitrust lawyer with proven expertise in Austrian and EU merger control.
GRAWE Banking Group, advised by E+H, undertakes reorganization
The GRAWE Banking Group, which is wholly owned by Grazer Wechselseitige Versicherung (GRAWE), has simplified its structure through two intra-group mergers in order to further increase efficiency in the Group.